2009
DOI: 10.1016/j.cca.2008.09.018
|View full text |Cite
|
Sign up to set email alerts
|

Soluble P-selectin as a marker of in vivo platelet activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
72
1
12

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 105 publications
(89 citation statements)
references
References 26 publications
4
72
1
12
Order By: Relevance
“…The sample size did not allow for stratified analysis to control for a potential confounding effect of endothelial-derived sP-selectin on the correlation with CCN1. However, the combination of evidence suggesting that sP-selectin is primarily platelet-derived and our previous results demonstrating that platelets carry and release CCN1 suggests the risk of confounding to be limited [18,43]. Furthermore, It cannot be ruled out that blood loss, fluid replacement, or other factors, such as anesthesia, may have masked the responses of CCN1 to surgery.…”
Section: Discussionmentioning
confidence: 89%
“…The sample size did not allow for stratified analysis to control for a potential confounding effect of endothelial-derived sP-selectin on the correlation with CCN1. However, the combination of evidence suggesting that sP-selectin is primarily platelet-derived and our previous results demonstrating that platelets carry and release CCN1 suggests the risk of confounding to be limited [18,43]. Furthermore, It cannot be ruled out that blood loss, fluid replacement, or other factors, such as anesthesia, may have masked the responses of CCN1 to surgery.…”
Section: Discussionmentioning
confidence: 89%
“…To further support the role of platelets in the generation of CD34 ϩ /KDR ϩ in vivo, we compared the levels of soluble P-selectin (sP-sel) as a marker for in vivo platelet activation 17 in the placebo and aspirin-treated patients. Aspirin treatment did not affect the average values of sP-sel between the placebo and aspirin-treated groups (51.1Ϯ4.9 versus 54.3Ϯ6.0 ng/mL, respectively; Pϭ0.437; Figure 4C).…”
Section: /Kdrmentioning
confidence: 99%
“…Once the arterial endothelium becomes injured, subendothelial components such as collagen [20] and von Willebrand factor [21] are exposed, resulting in the adherence of platelets to the damaged vessel wall and their subsequent activation. Activated platelets (P-selectinpositive platelets) release stromal cell-derived factor-1 (SDF-1) [22]. And co-cultivation experiments showed that human platelets recruit CD34-positive cells via specific adhesion receptors P-selectin/PSGL-1 and beta1-and beta2-integrins.…”
Section: Discussionmentioning
confidence: 99%